GGrantIndex
Sort

78,016 grants matching breast cancer

CCR, LGI, Flow Cytometry Core Facility

$1,166,067
Ferenc Livak · Division Of Basic Sciences - Nci · ZIC · FY2017 · CA

Genetics and Epigenetics of Cancer

$1,165,850
Maxwell Lee · Division Of Cancer Epidemiology And Genetics · ZIA · FY2009 · CA

A NOVEL PRECLINICAL MODEL OF DORMANT METASTATIC ER+ BREAST CANCER

$1,165,808
University Of Illinois · · FY2016 · Department of the Army

TARGETING FASN FOR BREAST CANCER TREATMENT BY REPOSITIONING PPIS

$1,165,799
Trustees Of Indiana University · · FY2016 · Department of the Army

Overcoming Barriers to Effective Care for Minorities

$1,165,751
Mount Sinai School Of Medicine Of Nyu · P60 · FY2003 · MD

TARGETING AN EPIGENETIC REGULATOR TO SUPPRESS BREAST CANCER METASTASIS

$1,165,498
Yale Univ · · FY2014 · Department of Defense

JAGGED AS A THERAPEUTIC TARGET IN BREAST CANCER

$1,165,383
University Of Illinois · · FY2018 · Department of the Army

VCU Massey Cancer Center Minority/Underserved NCI Community Oncology Research Program

$1,165,162
Khalid Matin · Virginia Commonwealth University · UG1 · FY2021 · CA

Advanced Imaging Methods in Pulse EPR

$1,164,814
Mrignayani Kotecha · O2m Technologies, Llc · R44 · FY2025 · CA

Systematic Identification and Pharmacological Targeting of Tumor Dependencies for Precision Cancer Medicine

$1,164,547
Andrea Califano · Columbia University Health Sciences · U01 · FY2017 · CA

CHROMOSOMAL INSTABILITY AS A DETERMINANT OF PACLITAXEL SENSITIVITY IN BREAST CANCER

$1,164,414
University Of Wisconsin System · · FY2016 · Department of Defense

APT: the Analytical Proteomics Team

$1,164,358
Fred E Regnier · Purdue University · U24 · FY2008 · CA

Role of Ets Genes in transformation and Differentiation

$1,163,737
Dennis K Watson · Medical University Of South Carolina · P01 · FY2009 · CA

1/3) MMC, VICC, and TSU: Partners in Eliminating Cancer Disparities

$1,163,643
Samuel E. Adunyah · Meharry Medical College · U54 · FY2025 · CA

A C. elegans localization-of-expression mapping project

$1,163,496
Dana-Farber Cancer Institute · R33 · FY2005 · CA

MOLECULAR ONCOLOGY PROGRAM PROJECT

$1,163,442
University Of South Florida · P01 · FY2002 · CA

Nox family NADPH oxidases: roles in innate immunity and inflammatory disease

$1,163,165
Thomas Leto · National Institute Of Allergy And Infectious Diseases · ZIA · FY2015 · AI

Rewired Signaling at the Nexus of Melanoma Metastasis and Resistance

$1,162,978
Ze'ev A Ronai · Sanford Burnham Prebys Medical Discovery Institute · R35 · FY2016 · CA

IDENTIFICATION OF ACTIONABLE NETWORKS PROMOTING BREAST CANCER PROGRESSION AND BRAIN METASTASIS

$1,162,801
Duke University · · FY2018 · Department of the Army

SPORE in Breast Cancer

$1,162,609
Jennifer A Pietenpol · Vanderbilt University Medical Center · P50 · FY2018 · CA

SPORE in Breast Cancer

$1,162,500
Joe W. Gray · University Of California, San Francisco · P50 · FY2008 · CA

Mechanisms By Which Maternal And Fetal Drug Exposure Is*

$1,162,448
Jashvant D Unadkat · University Of Washington · P50 · FY2006 · HD

Targeting pancreatic cancer metastases with Targefrin

$1,162,000
Carlo Baggio · Armida Labs, Inc. · R44 · FY2025 · CA

New Radiopharmaceuticals and New Paradigms in Positron Emission Tomography

$1,161,792
Dale O Kiesewetter · National Institute Of Biomedical Imaging And Bioengineering · Z01 · FY2008 · EB

Anastrozole in Pulmonary Arterial Hypertension (AIPH2) - CCC (Lead)

$1,160,837
Steven M Kawut · University Of Pennsylvania · R01 · FY2017 · HL